ArticlePloS one2025
Myoconjunctival Enucleation Study (MES): Outcome of Myoconjunctival Enucleation Technique with Polymethyl Methacrylate (PMMA) implant and Custom-made prosthesis (CMP) in a tertiary eye care center in Nepal.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the average motility of the implant and custom-made prosthesis (CMP) in various gazes following Myoconjunctival enucleation, the surgical duration, and the complications encountered at a tertiary eye hospital.
methodsThis was a prospective, non-randomized interventional study. Recti muscles were sutured to the fornices before enucleation of the eyeball to minimize surgical time and the need for additional sutures. Thirty-five consecutive patients meeting the inclusion criteria were enrolled. Data on surgery time, complications, and implant/prosthesis motility were recorded and analyzed.
resultsThe mean surgical duration was 39.43 ± 4.97 minutes. Mean PMMA implant movement was 2.34 mm in elevation, 2.26 mm in depression, 2.74 mm in abduction, and 2.71 mm in adduction. Custom-made prosthesis (CMP) movement was 2.40 mm in elevation, 2.51 mm in depression, 2.74 mm in abduction, and 2.66 mm in adduction. Complications were minimal: one intraoperative superior rectus slippage, a few cases with early postoperative nausea, vomiting, and headache, all resolved within a week. At six weeks, one suture granuloma and one shallow inferior fornix were noted and managed. Patient satisfaction was high (88.57%), with a mean Likert score of 4.25 ± 0.65 (1 = Very unsatisfied to 5 = Very satisfied). No patient reported dissatisfaction.
conclusionMyoconjunctival enucleation offers favorable implant and prosthesis motility, a relatively short surgical duration, and minimal complications. High patient satisfaction supports the myoconjunctival enucleation technique as a reliable and well-tolerated surgical option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.